Sofosbuvir and Velpatasvir with or Without Voxilaprevir in Direct‐acting Antiviral‐naïve Chronic Hepatitis C: Patient‐reported Outcomes from POLARIS 2 and 3

Z. M. Younossi,M. Stepanova,I. M. Jacobson,T. Asselah,E. J. Gane,E. Lawitz,G. R. Foster,S. K. Roberts,A. J. Thompson,B. E. Willems,T. M. Welzel,B. Pearlman,I. Younossi, A. Racila,L. Henry

Alimentary pharmacology & therapeutics（2017）

Cited 49|Views34

No score

Abstract

Chronic hepatitis C infection leads to impairment of patient‐reported outcomes (PROs). Treatment with direct‐acting antiviral regimens results in short‐ and long‐term improvement of these outcomes.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined